HOME >> MEDICINE >> NEWS
Leading American, German chemists converge to share research, vision

A group of 70 American and German chemists, age 40 or younger, will meet later this month in Durham, N.H. to share scientific ideas and results in leading areas of chemical research, including biomolecular engineering and bioinspired materials, molecular electronics, nanooptics and frontiers in synthesis.

The German-American Frontiers of Chemistry Symposium to be held August 23-25 at the New England Center in Durham is sponsored by the American Chemical Society, the worlds largest scientific society, and the German Chemical Society (Gesellschaft Deutscher Chemiker). Participants were selected by the symposiums organizing committees.

The symposium, which draws elite chemists from academia and industry in each country, provides a forum for chemists to learn about cutting-edge research in each others countries and in areas beyond their own specialties.

Speakers at the symposium will include: Eli Pearce, Ph.D., ACS president and university research professor at Polytechnic University in Brooklyn, N.Y; Gesellschaft Deutscher Chemiker Secretary General Heindirk tom Dieck, Ph.D.; and George Atkinson, Ph.D., University of Arizona professor and Senior Fellow for Science, Technology and Diplomacy at the U.S. Department of State.

The inaugural Frontiers of Chemistry Symposium was held in 2000 in Munich, Germany.

WHAT:
German-American Frontiers of Chemistry Symposium

WHERE:
New England Center in Durham, N.H

WHEN:
Aug. 23-25, 2002


'"/>

Contact: Tiffany Steele McAvoy
t_mcavoy@acs.org
202-872-6042
American Chemical Society
5-Aug-2002


Page: 1

Related medicine news :

1. Leading researchers in allergic disease to gather for 2005 AAAAI Annual Meeting
2. Leading tobacco manufacturer conceals links to tobacco research facility
3. Leading MRSA experts address emergence of superbug
4. Leading causes of blindness for blacks and whites different
5. Leading cancer doctor calls for new guidelines to control early reporting from clinical trials
6. Leading AIDS experts criticize US-sponsored HIV vaccine trial in Thailand
7. Leading the way in novel anti-cancer research
8. Leading anti-cancer factions strengthen bonds
9. Leading NIH-funded medical schools agree on guidelines that would strenghten conflict of interest policies
10. Biochemical Marker Targets Brain Injury Leading To Movement Problems After Stroke
11. New Model Shows How To Eradicate Worlds Leading Infectious Cause Of Blindness

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/20/2017)... ... June 20, 2017 , ... Caduceus ... is pleased to announce a new online course entitled Personal & Community ... insights and evidence-based strategies for achieving optimal well-being and teaches students how to ...
(Date:6/20/2017)... ... 20, 2017 , ... Fresenius Vascular Care, a national network of outpatient vascular ... manage a wide range of vascular conditions, has today announced its new name, Azura ... represented by more than 40 local brands, a phased rollout of the new brand ...
(Date:6/20/2017)... (PRWEB) , ... June 20, 2017 , ... ... report contending that the introduction of school choice can promote economic development in ... charter school that has, according to the report, contributed to the economic development ...
(Date:6/20/2017)... ... June 20, 2017 , ... AMC Health , ... and success in the clinical trials market. Similar to its approach in demonstrating positive ... the clinical trials marketplace by proving the value of eVisits to support virtual studies. ...
(Date:6/20/2017)... ... June 20, 2017 , ... Leading dental clinicians, Drs. Ashlyn ... with the VATECH PaX-i and Anatomage systems. With advanced digital images and modeling capabilities, ... place dental implants precisely and restore oral health for those who are missing ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... Inc., (Nasdaq: NVAX ) today announced that data ... RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) ... the journal Vaccine (the data contained ... The Company previously announced top line results from ... F Vaccine with the goal of protecting infants from RSV ...
(Date:6/3/2017)... , June 3, 2017  Eli Lilly ... announced that results from the Phase 3 MONARCH ... (CDK)4 & 6 inhibitor, in combination with fulvestrant, ... with fulvestrant alone in women with hormone-receptor-positive (HR+), ... breast cancer who have relapsed or progressed after ...
(Date:5/30/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will present ... Conference on Tuesday, June 13, 2017, in Rancho ... president and chief executive officer, is scheduled to present at ... can be accessed at http://ir.hill-rom.com/events.cfm . A recorded replay ... event through September 13, 2017. ...
Breaking Medicine Technology:
Cached News: